#Anthropic

Anthropic has become one of the strongest AI narratives in the market. The company behind Claude has seen an extraordinary increase in its private-market valuation. Reports indicate that Anthropic raised around $30 billion at a $380 billion valuation in February 2026, followed by a $65 billion Series H at approximately $965 billion in May. Secondary-market transactions have reportedly pushed implied valuations toward $1.5 trillion, while the ANTHROPICUSDT market has at times reflected an implied valuation around $1.8 trillion.

The fundamental growth story is also attracting major attention. Reports have pointed to rapidly increasing revenue, strong enterprise demand and significant growth from Claude and Claude Code. Some estimates suggest Anthropic could generate around $10.9–$11.5 billion in quarterly revenue, while Claude Code has reportedly reached approximately $1 billion in annualized revenue. Enterprise AI market-share data has also shown strong competition between Anthropic and OpenAI. These developments are important reasons behind the strong bullish sentiment surrounding Anthropic.

The key question now is how far ANTHROPICUSDT can realistically move. If the market continues pricing Anthropic toward a potential $2 trillion valuation ahead of a future IPO, the current $1,800–$1,865 area could still have upside potential. However, the closer the price gets to $2,000, the more important valuation expectations and official IPO developments become. A higher valuation would require continued business growth and strong investor demand rather than simply market hype.

From a technical perspective, the $1,840–$1,900 region is the first major resistance zone. A strong breakout and sustained trading above $1,900 could open the door toward the psychological $2,000 level. Above $2,000, the next upside zones could be around $2,100–$2,150, while $2,300 would represent a more aggressive target that would likely require a much stronger valuation narrative.

On the downside, $1,600 is the first major psychological support. If this level holds during a pullback, the broader bullish structure could remain intact. Below $1,600, the next important area is around $1,500, followed by approximately $1,350–$1,400. These levels should be watched carefully because a decisive breakdown could indicate that market expectations are cooling.

My overall view is cautiously bullish, but I would not recommend chasing a sharp vertical move.

Anthropic has a strong fundamental growth narrative, but ANTHROPICUSDT remains a pre-IPO derivative rather than publicly listed equity.

Its pricing can therefore be heavily influenced by sentiment, liquidity, speculation and expectations about a future IPO.

For a hypothetical trading plan, a confirmation above $1,900 could provide a momentum setup toward TP1 at $1,950–$2,000, TP2 at $2,100–$2,150 and an aggressive TP3 near $2,300 if the valuation narrative becomes significantly stronger.

For risk management, possible invalidation levels could be SL1 around $1,760, SL2 around $1,650 and a wider structural SL3 near $1,500. These are example levels rather than guaranteed protection points, and actual execution can differ because of volatility, spreads and liquidity.

The most important things to monitor are official IPO announcements, valuation updates, revenue growth, secondary-market activity, liquidity and overall investor sentiment. If ANTHROPICUSDT successfully breaks and holds above $1,840–$1,865 and then clears $1,900, the bullish momentum could strengthen. On the other hand, a sustained move below $1,600 would significantly weaken the current bullish thesis and could bring $1,500 and $1,350–$1,400 into focus.

The key lesson is simple: this is a high-potential but high-volatility pre-IPO market. The biggest opportunity may come from disciplined entries around important support or confirmed breakouts rather than blindly chasing a strong rally. Position size should remain small, leverage should be conservative, and the exit plan should be decided before entering.

Until Anthropic officially becomes a publicly listed company, the market price of this instrument should be treated as an expectation-driven valuation rather than a direct reflection of publicly traded shares. That creates both significant opportunity and significant risk.

Stay patient, protect capital and let confirmation—not hype—guide the trade.